LDH | Lactic dehydrogenase |
VEGF | Vascular endothelial growth factor |
NF-κB | Nuclear factor kappa B |
PCa | Prostatic cancer |
KLF6 | Kruppel-like factor 6 |
Bcl-2 | B-cell lymphoma-2 |
ROS | Reactive oxygen species |
MMP-2 | Matrix Metalloproteinase-2 |
RCC | Renal cell carcinoma |
HCC | Hepatocellular Carcinoma |
MVA pathway | Mevalonate pathway |
TCTP | Translation-controlled tumor protein |
PCD | Programmed cell death |
IL-10 | Interleukin-10 |
NF-κB | Nuclear factor κB |
IL-1β | Interleukin 1β |
COX-2 | Cyclooxygenase-2 |
NSCLC | Non-small cell lung cancer |
EMT | Epidermal interstitial transformation |
ESCC | Esophageal squamous cell carcinoma |
ATC | Anaplastic thyroid carcinoma |
mTOR | Mammalian target of rapamycin |
HNC | Head and neck cancer |
API | Active pharmaceutical ingredient |
PCa | Prostate cancer |
AR | Androgen receptor |
NF1 | Neurofibromatosis type1 |
MPNST | Malignant peripheral nerve sheath tumors |
FIGO | International Federation of Gynecology and Obstetrics |
EC | Esophageal cancer |
ADM | Doxorubicin |